AbbVie says it will take meaningful share of hepatitis C market
January 30, 2015 at 09:36 AM EST
Jan 30 (Reuters) - AbbVie Inc's top executive said on Friday that the company's new hepatitis C treatment Viekira Pak has the potential to capture a "meaningful share" of the U.S. market, where it is competing against Gilead Sciences Inc .
